(Q44941164)

7 December 2017

Three-year clinical follow-up of an unselected patient population treated with the genous endothelial progenitor cell capturing stent (English)

1 reference

7 December 2017

0 references

Pier Woudstra

4

0 references

Jan G. P. Tijssen

6

object named as

Jan G P Tijssen

1 reference

7 December 2017

Margo Klomp

1

1 reference

7 December 2017

Marcel A M Beijk

2

1 reference

7 December 2017

Peter Damman

3

1 reference

7 December 2017

Karel T Koch

5

1 reference

7 December 2017

Robbert J de Winter

7

1 reference

7 December 2017

1 October 2011

1 reference

Journal of Interventional Cardiology

7 December 2017

1 reference

7 December 2017

24

1 reference

7 December 2017

5

1 reference

7 December 2017

442-449

1 reference

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

7 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Drug-eluting versus bare-metal stents in large coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Drug-eluting stents: caution and concerns for long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Late angiographic stent thrombosis (LAST) events with drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Clinical end points in coronary stent trials: a case for standardized definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Three year follow-up of the sirolimus-eluting stent and the paclitaxel-eluting stent in daily practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Long-term (>3 Years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2011.00665.X

10.1111/J.1540-8183.2011.00665.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference